Login / Signup

Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease.

Alessandro GiallongoGiuseppe Fabio ParisiMaria PapaleSara MantiEnza MuléDonatella AloisioVito TerlizziNovella RotoloSalvatore Leonardi
Published in: Genes (2023)
We provide further evidence on the efficacy of the CFTR modulators ELX/TEZ/IVA, adding information about their effect on the respiratory muscles' performance and cardiorespiratory polygraphy parameters in CF patients with severe lung disease.
Keyphrases
  • cystic fibrosis
  • pseudomonas aeruginosa
  • lung function
  • body composition
  • early onset
  • high intensity
  • respiratory tract
  • drug induced
  • healthcare
  • health information